Sonata Capital Group’s Merck MRK Stock Holding History

Sonata Capital Group’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$326K	Sell	2,539 -288	-10%	-$33.7K	0.11%	98
2026 Q1	$340K	Sell	2,827 -141	-5%	-$16.3K	0.13%	94
2025 Q4	$312K	Buy	2,968 +2	+0.1%	+$188	0.11%	96
2025 Q3	$249K	Sell	2,966 -1,397	-32%	-$115K	0.09%	112
2025 Q2	$345K	Sell	4,363 -497	-10%	-$39.5K	0.14%	83
2025 Q1	$436K	Sell	4,860 -1,848	-28%	-$173K	0.19%	77
2024 Q4	$667K	Buy	6,708 +2	+0%	+$206	0.28%	60
2024 Q3	$762K	Buy	6,706 +1	+0%	+$119	0.32%	56
2024 Q2	$830K	Buy	6,705 +2	+0%	+$258	0.43%	41
2024 Q1	$884K	Buy	6,703 +2	+0%	+$247	0.4%	49
2023 Q4	$731K	Sell	6,701 -498	-7%	-$51.7K	0.36%	50
2023 Q3	$741K	Sell	7,199 -289	-4%	-$31.1K	0.4%	47
2023 Q2	$864K	Sell	7,488 -248	-3%	-$28.2K	0.45%	45
2023 Q1	$823K	Sell	7,736 -248	-3%	-$26.8K	0.45%	44
2022 Q4	$886K	Sell	7,984 -499	-6%	-$51K	0.49%	41
2022 Q3	$731K	Sell	8,483 -374	-4%	-$33.4K	0.4%	50
2022 Q2	$807K	Buy	8,857 +2	+0%	+$177	0.42%	49
2022 Q1	$727K	Sell	8,855 -372	-4%	-$29.3K	0.32%	58
2021 Q4	$707K	Buy	9,227 +2	+0%	+$159	0.3%	64
2021 Q3	$693K	Sell	9,225 -1,191	-11%	-$90.6K	0.31%	60
2021 Q2	$810K	Sell	10,416 -498	-5%	-$37K	0.37%	57
2021 Q1	$803K	Sell	10,914 -2,094	-16%	-$154K	0.39%	58
2020 Q4	$1.01M	Buy	13,008 +1	+0%	+$76	0.5%	50
2020 Q3	$1.03M	Buy	13,007 +2	+0%	+$157	0.6%	43
2020 Q2	$960K	Buy	13,005 +2	+0%	+$151	0.61%	41
2020 Q1	$955K	Sell	13,003 -312	-2%	-$24.5K	0.72%	38
2019 Q4	$1.16M	Buy	13,315 +1	+0%	+$82	0.7%	38
2019 Q3	$1.07M	Buy	13,314 +81	+0.6%	+$6.49K	0.72%	36
2019 Q2	$1.06M	Sell	13,233 -392	-3%	-$30K	0.73%	34
2019 Q1	$1.08M	Buy	13,625 +2	+0%	+$150	0.81%	29
2018 Q4	$993K	Sell	13,623 -72	-0.5%	-$5.08K	0.81%	30
2018 Q3	$927K	Sell	13,695 -206	-1%	-$13.1K	0.63%	37
2018 Q2	$805K	Buy	13,901 +526	+4%	+$29.7K	0.58%	39
2018 Q1	$695K	Buy	13,375 +3	+0%	+$162	0.51%	43
2017 Q4	$718K	Sell	13,372 -785	-6%	-$43.5K	0.52%	43
2017 Q3	$865K	Buy	14,157 +2	+0%	+$121	0.64%	37
2017 Q2	$866K	Sell	14,155 -417	-3%	-$25.4K	0.65%	37
2017 Q1	$884K	Sell	14,572 -1,047	-7%	-$63.5K	0.67%	35
2016 Q4	$877K	Buy	15,619 +2	+0%	+$117	0.68%	34
2016 Q3	$930K	Buy	15,617 +2	+0%	+$117	0.76%	31
2016 Q2	$858K	Sell	15,615 -628	-4%	-$33.4K	0.73%	34
2016 Q1	$820K	Sell	16,243 -207	-1%	-$10.1K	0.71%	36
2015 Q4	$829K	Buy	16,450 +2	+0%	+$101	0.73%	33
2015 Q3	$775K	Buy	16,448 +209	+1%	+$11.1K	0.72%	34
2015 Q2	$882K	Buy	16,239 +1,048	+7%	+$58.8K	0.76%	30
2015 Q1	$833K	Buy	15,191 +472	+3%	+$26.7K	0.73%	33
2014 Q4	$798K	Buy	+14,719	New	+$820K	0.72%	32

Other funds holding MRK

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Sonata Capital Group's MRK Position: Q2 2026 in Review

Sonata Capital Group reduced its Merck (MRK) stake by 10% in Q2 2026, selling an estimated $33.7K and leaving 2,539 shares worth $326K. The position accounts for 0.11% of the portfolio, ranked #98.

Sonata Capital Group first reported a position in MRK in Q4 2014 and has held it in 47 quarters since. The position peaked at $1.16M in Q4 2019. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Sonata Capital Group held 2,539 shares of Merck worth $326K as of Q2 2026.
Sonata Capital Group sold 288 Merck shares in Q2 2026, an estimated $33.7K.
Merck made up 0.11% of Sonata Capital Group's portfolio in Q2 2026, its #98 holding.
Sonata Capital Group first reported a position in Merck in Q4 2014 and has held it in 47 quarters since.
Sonata Capital Group's Merck position peaked at $1.16M in Q4 2019.
1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Sonata Capital Group's 13F filing for Q2 2026, filed 24 Jul 2026.